CH
RVMD icon

Cromwell Holdings’s Revolution Medicines RVMD Stock Holding History

Cromwell Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.68K Buy
41
+13
+46% +$1.9K ﹤0.01% 626
2026
Q1 		$2.72K Hold
28
– – ﹤0.01% 661
2025
Q4 		$2.23K Hold
28
– – ﹤0.01% 675
2025
Q3 		$1.31K Buy
+28
New +$1.1K ﹤0.01% 780

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Cromwell Holdings's RVMD Position: Q2 2026 in Review

Cromwell Holdings increased its Revolution Medicines (RVMD) stake by 46% in Q2 2026, buying an estimated $1.9K and bringing the position to 41 shares worth $7.68K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Cromwell Holdings first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 93 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Cromwell Holdings held 41 shares of Revolution Medicines worth $7.68K as of Q2 2026.
  • Cromwell Holdings bought 13 Revolution Medicines shares in Q2 2026, an estimated $1.9K.
  • Revolution Medicines made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #626 holding.
  • Cromwell Holdings first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 93 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.